Reaction Details Report a problem with these data
Target
Protachykinin-1
Ligand
BDBM50095890
Substrate
n/a
Ki
1000±n/a nM
Comments
PDSP_1571
Citation
 Schotte, A; Janssen, PF; Gommeren, W; Luyten, WH; Van Gompel, P; Lesage, AS; De Loore, K; Leysen, JE Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57-73 (1996) [PubMed]  Article 
Target
Name:
Protachykinin-1
Synonyms:
NKA | NKNA | Protachykinin-1 | Substance P | TAC1 | TAC2 | TKN1_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15006.99
Organism:
Homo sapiens (Human)
Description:
Substance P 0 HUMAN::P20366
Residue:
129
Sequence:
MKILVALAVFFLVSTQLFAEEIGANDDLNYWSDWYDSDQIKEELPEPFEHLLQRIARRPKPQQFFGLMGKRDADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLMGKRALNSVAYERSAMQNYERRR
  
Inhibitor
Name:
BDBM50095890
Synonyms:
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol | 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol | CHEMBL716 | QUETIAPINE
Type:
Small organic molecule
Emp. Form.:
C21H25N3O2S
Mol. Mass.:
383.507
SMILES:
OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12 |t:13|
Structure:
Search PDB for entries with ligand similarity: